Pharmacoeconomic analysis of adjuvant use of zonisamide therapy resistant partial epilepsy in adults
The purpose of pharmacoeconomic studies of the drug zonisamide is to determine it’s clinical and cost-effectiveness in adult patients with refractory partial epilepsy in comparison with other new antiepileptic drugs in the conditions of the Russian Federation. Target population are Russian patients...
Main Authors: | D. Yu. Belousov, E. V. Afanasyeva, E. A. Efremova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-06-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/203 |
Similar Items
-
Pharmacoeconomic analysis of perampanel for resistance partial epilepsy
by: D. Yu. Belousov, et al.
Published: (2018-06-01) -
Результаты проведения фармакоэкономических анализов при лечении болезни Паркинсона агонистом дофаминовых рецепторов Мирапексом
Published: (2018-06-01) -
Фармакоэкономический анализ применения противопаркинсонических препаратов в режиме монотерапии на ранних стадиях болезни Паркинсона
Published: (2018-06-01) -
Типы и методы проведения научного анализа исходов
Published: (2018-06-01) -
Pharmacoeconomic analysis of naft idrofuryl in patients with chronic obliterating diseases of lower limb arteries
by: A. E. Cheberda, et al.
Published: (2018-05-01)